Cryptocurrency & Digital Assets

With a new luxury-focused role and a veteran leader, footwear giant Caleres signals a major strategic investment in its high-end New York brands.

The iconic basketball-playing dog is back! Cineverse and Air Bud Entertainment are betting on nostalgia and a new story to relaunch a beloved franchise.

As PHINIA preps for its NYSE Investor Day, it plans to prove its value by balancing legacy engine tech with bold investments in a lower-carbon future.

New F1 hybrid cannabis seeds deliver unprecedented yields and uniformity, potentially transforming the industry from large-scale farms to home growers.

Celebrating 100 years in the Caribbean, Holland America Line doubles down on its classic, relaxed cruise style, contrasting with today's mega-ship trend.

Regulators deem PRRS-resistant pigs safe, promising a future with less animal disease and antibiotic use, but sparking debate on consumer transparency.

South Korean fintech leader Hecto Financial integrates with Circle's network, leveraging USDC for faster, cheaper global payments amid evolving regulations.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

Tractor Beverage's Haymaker line earns a stringent purity certification, signaling a major retail pivot where 'organic' is no longer the final word.

The 'better-for-you' brand is making a massive retail play, adding new executives and launching innovative gummies to capture the $100B energy market.

Eli Lilly partners with China's Zonsen PepLib, betting on its novel peptide platforms to fuel the next wave of therapies in oncology and metabolism.

As CFO Mike Santomassimo prepares for the UBS conference, investors seek clarity on Wells Fargo's strategy after its asset cap removal and rate cut impacts.

A breakthrough in cancer therapy as Avacta's faridoxorubicin proves so safe, regulators have removed historic dosing limits tied to heart toxicity.

The convenience store giant released preliminary 2025 financials as its subsidiary, ARKO Petroleum Corp., launches a high-stakes IPO roadshow.

Promega's new diagnostic for KEYTRUDA gains NMPA approval, opening doors for targeted solid tumor therapy amid China's growing precision medicine market.

Returning to the prestigious list, the homebuilder's No. 2 rank reflects strategic resilience, ESG focus, and innovation in a shifting housing market.

MINISO is betting its future on becoming an IP powerhouse, launching immersive stores and a multi-million dollar talent hunt to create its own characters.

Amid a relentless outbreak, Brazil launches a massive pilot program for the IXCHIQ® vaccine, a critical test for public health and global preparedness.